Filter
1374
Filtered Results: 1374
Text search:
Ministry
of
Health,
Ethiopia
Featured
Recommendations
98
New Publications
359
Language
Document type
No document type
756
Studies & Reports
336
Guidelines
114
Manuals
60
Strategic & Response Plan
58
Training Material
21
Situation Updates
14
Fact sheets
9
Resource Platforms
3
Brochures
1
App
1
Infographics
1
Countries / Regions
Ethiopia
252
Global
82
Kenya
81
Africa
57
Uganda
38
Nigeria
29
Malawi
28
Rwanda
27
South Sudan
27
Ghana
22
Zambia
20
Liberia
20
Sierra Leone
18
Tanzania
18
East and Southern Africa
18
Senegal
17
Congo, Democratic Republic of
15
South Africa
13
Guinea
12
Zimbabwe
11
Mozambique
11
Sudan
10
Somalia
10
Nepal
9
West and Central Africa
9
India
9
Madagascar
9
Cameroon
8
Cambodia
8
Burkina Faso
7
Namibia
7
Yemen
7
Lesotho
6
Latin America and the Carribbean
6
South–East Asia Region
6
Western and Central Europe
6
Bangladesh
6
Botswana
6
Pakistan
6
Benin
5
Afghanistan
5
Middle East and North Africa
5
Indonesia
5
Syria
4
Côte d’Ivoire / Ivory Coast
4
Central African Republic
4
Mali
4
Myanmar / Burma
4
Colombia
3
Ukraine
3
Togo
3
China
3
Haiti
3
Jordan
3
Chad
3
Thailand
2
Mexico
2
Iran
2
Philippines
2
Asia
2
Guinea-Bissau
2
Southern Africa
2
Lebanon
2
Eastern Europe
2
Russia
2
Djibouti
2
Greece
2
Angola
2
Libya
2
Iraq
2
North Macedonia
1
North Korea
1
Gambia
1
Albania
1
Canada
1
Laos
1
Niger
1
Burundi
1
Peru
1
Vanuatu
1
Morocco
1
Italy
1
Germany
1
Saudi Arabia
1
Eastern Europe and Central Asia
1
Gabon
1
Mauritius
1
Tunisia
1
Morocco
1
Vietnam
1
Papua New Guinea
1
Brazil
1
Palestine
1
Georgia
1
Solomon Islands
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
559
Women & Child Health
98
Public Health
90
Key Resources
90
Clinical Guidelines
89
Capacity Building
27
Pharmacy & Technologies
10
Toolboxes
HIV
111
COVID-19
98
TB
75
Mental Health
71
Disability
68
Planetary Health
60
NTDs
58
Rapid Response
41
AMR
41
Caregiver
40
Refugee
35
Conflict
35
Health Financing Toolbox
29
Global Health Education
28
Pharmacy
23
Ebola & Marburg
19
NCDs
16
Cholera
14
Natural Hazards
8
Polio
7
Specific Hazards
4
South Sudan
2
Malaria
1
Zika
1
Addressing comorbidities and risk factors for tuberculosis (TB) is a crucial component of the World Health Organization (WHO)’s End TB Strategy. This WHO operational handbook on tuberculosis. Module 6: tuberculosis and comorbidities aims to support countries in scaling up people-centred care, ...
Cholera is a major health risk in many parts of the world, affecting millions of people every year. Since mid-2021, the world has been facing an acute upsurge of the 7th cholera pandemic, which is characterized by the number, size and concurrence of multiple outbreaks, the spread to areas that had b...
22 December 2020
The COVID-19 vaccine safety guidance manual has been developed upon recommendation and guidance of GACVS members, as well as by experts incorporating current and available information critical to all stakeholders when COVID-19 vaccines will be introduced.
For ease of use, the man...
The KMC implementation strategy targets a broad audience. These include policy-makers and programme managers at national, regional and local levels, government and nongovernmental organizations working in the area of maternal and newborn care, global and national professional associations, public an...
The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world.
In addition, this edition includes summary and recommendations from the virtual meeting of the members of the WHO Programme f...
Latent Tuberculosis Infection : Updated and consolidated guidelines for programmatic management
recommended
The consolidated guidelines are expected to provide the basis and rationale for the development of national guidelines for LTBI management, adapted to the national and local epidemiology of TB, the availability of resources, the health infrastructure and other national and local determinants. The gu...
In 2017, 3.6 million of the estimated 10 million people with TB worldwide were “missed” by national TB programmes (NTPs). Two thirds of them are thought to access TB treatment of questionable quality from public and private providers who are not engaged by the NTP. The quality of care provided i...
Hepatitis B (HBV) infection is a major public health problem and cause of chronic liver disease.
The 2024 HBV guidelines provide updated evidence-informed recommendations on key priority topics. These include expanded and simplified treatment criteria for adults but now also for adolescents; expa...
This manual summarizes key issues related to the safety of NTD medicines and their administration, with a focus on essential medicines used in mass drug administration (MDA), also called preventive chemotherapy. It can be used as a standalone reference manual, but is intended to be used in conjuncti...
Laboratory manual for yellow fever
recommended
This WHO laboratory manual provides the most up to date methods and procedures for the laboratory identification of yellow fever virus infection in humans. It provides guidance on the establishment and maintenance of an effective laboratory providing routine surveillance testing for yellow fever, wh...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
Since 1996, trachoma has been targeted for elimination as a public health problem worldwide. The active trachoma criterion for national elimination as a public health problem is a TF1–9 < 5%, sustained for at least two years in the absence of antibiotic mass drug administration (MDA), in each form...
WHO Guideline. Since 2010, countries in the meningitis belt have started to introduce a new serogroup A meningococcal conjugate vaccine conferring individual protection and herd immunity. Following the successful roll-out of this vaccine, epidemics due to Neisseria meningitidis serogroup A (NmA) are...
Global tuberculosis report 2022
recommended
The WHO Global Tuberculosis Report 2022 provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. This is done in the context of global TB commitments, strategies and targets.
...
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
mhGAP is based on evidence-based technical guidelines (4) and provides a set of tools and
training packages to extend service provision. The mhGAP Intervention Guide (mhGAP-IG)
for MNS disorders in non-specialized health settings (8) is a clinical decision-making tool
for assessing and managing p...
This report presents country, regional and global estimates of low birth weight for 2000, together with a detailed description of the methods used in calculating the estimates. Some limited data on trends are also included. The limitations of low-birth-weight data are described and recommendations a...
A guide to increasing coverage and equity in all communities in the African Region
Expanded Programs on Immunization (EPI) is responsible for vaccines and vaccination to control, eliminate and eradicate vaccine preventable diseases (VPDs). Having strong immunization systems to deliver vaccines ...
Expanded Programs on Immunization (EPI) is responsible for vaccines and vaccination to control, eliminate and eradicate vaccine preventable diseases (VPDs). Having strong immunization systems to deliver vaccines ...
This brief update on tuberculosis (TB) in the African region covers the state of TB in the WHO African region, strategic priorities and targets and the impact of COVID-19 on essential services. This is followed by key figures for the region, the role of WHO in country support and, recognizing the im...
Fact Book on WHO Level I and Level II monitoring indicators - To monitor the progress of efforts to improve the global medicines situation, WHO has developed a system of indicators that measure important aspects of a country’s pharmaceutical situation. Level 1 indicators measure the existence and ...
